ClinicalTrials.Veeva

Menu

Effects Of Intra-Operative Intra-Articular Cocktail Injection In Patella Open Reduction And Internal Fixation

The University of Hong Kong (HKU) logo

The University of Hong Kong (HKU)

Status and phase

Enrolling
Phase 4

Conditions

Patella Fracture

Treatments

Drug: Adrenaline 1:1000 0.5ml
Drug: Ropivacaine HCL 1% 15ml
Drug: Triamcinolone Acetonide 40mg
Drug: Ketorolac 15mg
Drug: 0.9 % Normal Saline 35ml

Study type

Interventional

Funder types

Other

Identifiers

NCT07006168
UW 24-611

Details and patient eligibility

About

The objective of this study is to demonstrate the safety and efficacy of an intra-articular analgesics cocktail injection for post-operative patella fracture fixation patients, by comparing post-operative pain relief and functional recovery among study subjects who received the injection and those who did not receive the injection. Secondary objective is to demonstrate the health economic effects of intra-articular analgesics cocktail injection by reducing length of hospital stay and reducing bed-stay related complications.

Full description

This is a single-centre, double-blinded, randomised control trial that evaluates the efficacy of intra-articular analgesics cocktail injection in post-operative pain relief and functional recovery for fractured patella fixation patients. The recruited study subjects will be randomised to the two study groups respectively in a 1:1 randomisation ratio.

Patella is the largest sesamoid bone in the human body, it acts as the fulcrum of our knee extensor apparatus and is important during the gait cycle. Patella fracture commonly occurs after a fall on a flexed knee. Treatment can be conservative or surgical with open reduction and internal fixation. Patients often experience significant pain around the knee post-operatively, limiting their walking ability and hindering their rehabilitation. As a result, total hospital stay will be prolonged, leading to hospital stay-related morbidity and additional healthcare economic burden.

Previous studies have shown that the use of an analgesic cocktail injection in arthroplasty cases can significantly reduce early postoperative pain and provide better early motion. The cocktail regime is as follows for a unilateral joint:

Ketoralac 15mg Ropivacaine 1% 15ml 0.9% Normal Saline 35ml Adrenaline 1:1000 0.5ml Stacort-A Triamcinolone Acetonide 40mg Total Cocktail Volume ~50ml

After fracture fixation, patients in the intervention group will receive an intra-articular injection of the above analgesic cocktail, while patients in the control group will not receive an injection.

Herein this study, the investigators hope to demonstrate the safety and efficacy of an intra-articular analgesics cocktail injection for post-operative patella fracture fixation patients.

Enrollment

56 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • acute patella fracture requiring open reduction and internal fixation;
  • able to consent to surgery;
  • pre-morbid able to ambulate

Exclusion criteria

  • open fracture;
  • polytrauma;
  • previous knee arthroplasty;
  • history of chronic pain,
  • insulin-dependent diabetes mellitus, or peptic ulcer disease;
  • chronic users of glucocorticoids, immunosuppressants, or immune-modulating agents, or of strong opioids (e.g.: morphine, fentanyl, hydromorphone, methadone, oxycodone, or meperidine);
  • hepatitis B or C carrier;
  • renal impairment (creatinine [Cr], >200 mmol/L)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

56 participants in 2 patient groups

Intra-Articular Cocktail Injection
Experimental group
Description:
After fixation, an intra-articular cocktail injection is injected into the surgical site. The intra-articular cocktail regime: Ketoralac 15mg, Ropivacaine 1% 15ml, 0.9% Normal Saline 35ml, Adrenaline 1:1000 0.5ml, Stacort-A Triamcinolone Acetonide 40mg. The total cocktail volume is approximately 50ml.
Treatment:
Drug: 0.9 % Normal Saline 35ml
Drug: Ketorolac 15mg
Drug: Triamcinolone Acetonide 40mg
Drug: Ropivacaine HCL 1% 15ml
Drug: Adrenaline 1:1000 0.5ml
No Injection
No Intervention group
Description:
No injection will be given to the patient.

Trial contacts and locations

1

Loading...

Central trial contact

Christian Fang; Christian FANG

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems